Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells

Hum Gene Ther. 1991 Spring;2(1):53-60. doi: 10.1089/hum.1991.2.1-53.

Abstract

Expression of a gene encoding the diphtheria toxin A (DT-A) fragment, controlled by tissue specific regulatory elements, has previously been used to kill selected cell populations. Here, we have examined the feasibility of controlling DT-A expression using regulatory systems from the human immunodeficiency virus (HIV-1) genome. Plasmids were constructed which express either DT-A or, as a model system, the luciferase (luc) reporter gene, under control of HIV-1 long terminal repeat (LTR) sequences (-167 to +80). While trans-activation by expression of the viral protein Tat was demonstrated, significant basal expression was observed. To reduce basal expression, cis-acting negative regulatory elements from the env region of the HIV-1 genome were inserted in the 3' untranslated region of both the luc and DT-A constructs. This dramatically reduced basal expression from the HIV LTR, and now both viral regulatory proteins Tat and Rev were required for maximal trans-activation. Such regulation of DT-A expression might be therapeutically applied to selectively kill HIV-infected cells in acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC).

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Diphtheria Toxin / biosynthesis
  • Diphtheria Toxin / genetics*
  • Gene Expression Regulation, Viral*
  • Gene Products, rev / physiology*
  • Gene Products, tat / physiology*
  • Genetic Therapy
  • Genetic Vectors
  • HIV Infections / therapy
  • HIV Long Terminal Repeat
  • HIV-1 / genetics*
  • Humans
  • Luciferases / biosynthesis
  • Luciferases / genetics
  • Promoter Regions, Genetic
  • Recombinant Fusion Proteins / biosynthesis
  • Recombinant Fusion Proteins / genetics
  • Transcription, Genetic
  • Transfection
  • Tumor Cells, Cultured
  • rev Gene Products, Human Immunodeficiency Virus
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Diphtheria Toxin
  • Gene Products, rev
  • Gene Products, tat
  • Recombinant Fusion Proteins
  • rev Gene Products, Human Immunodeficiency Virus
  • tat Gene Products, Human Immunodeficiency Virus
  • Luciferases